Perchellet, E.M., Y. Wang,K. Lou, H. Zhao, S.K. Battina, D.H. Hua, and J.P. Perchellet. 2007. Antitumor triptycene analogs directly interact with isolated mitochondria to rapidly trigger markers of permeability transition. Anticancer Res 27: 3259-3272.
Perchellet, E.M., Y. Wang, K. Lou, H. Zhao, S.K. Battina, D.H. Hua, J.P. Perchellet. 2007. Novel substituted 1,4 anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria. Int J Oncology 31: 1231-1241.
Hua, D.H., K. Lou, S.K. Battina, H. Zhao, E.M. Perchellet, Y. Wang, and J.P.
Perchellet. 2006. Syntheses, molecular targets and antitumor activities of novel triptycene
bisquinones and 1,4-anthracenedione analogs. Anti-Cancer Agents in
Medicinal Chemistry 6: 303-318.
Perchellet, E.M., M.M. Ward, A.-L. Skaltsounis, I.K. Kostakis, N. Pouli, P.
Marakos, and J.P. Perchellet. 2006. Antiproliferative and proapoptotic activities of pyranoxanthenones,
pyranothioxanthenones, and their pyrazole-fused derivatives in HL-60 cells. Anticancer Res 26: 2791-2804.
Wang,Y., E.M. Perchellet, M.M. Ward, K. Lou, H. Zhao, S.K. Battina, B.
Wiredu,D.H. Hua, and J.P. Perchellet. 2006. Antitumor triptycene analogs induce a rapid collapse of mitochondrial
transmembrane potential in HL-60 cells and isolated mitochondria. Int J
Oncology 28: 161-172.
Perchellet,
E.M., J.P. Perchellet, and P.W. Baures. 2005. Imidazole-4,5-dicarboxamide
derivatives with antiproliferative activity against HL-60 cells. J Med
Chem 48: 5955-5965.
Wang Y, E.M. Perchellet, M.M. Ward, K. Lou, D.H. Hua, and J.P. Perchellet.
2005. Rapid
collapse of mitochondrial transmembrane potential in HL-60 cells and isolated
mitochondria treated with antitumor 1,4-anthracenediones. Anti-Cancer
Drugs 16: 953-967.
Perchellet,
E.M., Y. Wang, R.L. Webe, K. Lou, D.H. Hua,and J.P. Perchellet. 2004. Antitumor
triptycene bisquinones induce a
caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of
initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve
Fas signaling. Anti-Cancer Drugs 15: 929-946.
Perchellet,
E.M., Y. Wang, R.L. Weber, B.J. Sperfslage, K. Lou, J. Crossland, D.H. Hua, and
J.P. Perchellet. 2004. Synthetic
1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3,
and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal
DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2
activation but not Fas signaling. Biochem
Pharmacol 67: 523-537.
Wang,
B., E.M. Perchellet, Y. Wang, M. Tamura, D.H. Hua, and J.P. Perchellet. 2003. Antitumor
triptycene bisquinones: a novel synthetic
class of dual inhibitors of DNA topoisomerase I and II activities. Anti-Cancer Drugs 14: 503-514.
Perchellet, E.M., B.J. Sperfslage, Y. Wang, X.
Huang, M. Tamura, D.H. Hua, and J.P. Perchellet.
2002. Among
substituted 9,10- dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones,
the lead antitumor triptycene bisquinone TT24 blocks
nucleoside transport, induces apoptotic DNA fragmentation and decreases the
viability of L1210 leukemic cells in the
nanomolar range of daunorubicin in vitro. Anti-Cancer Drugs 13: 567-582.
Wang, Y., E.M. Perchellet, M. Tamura, D.H. Hua,
and J.P. Perchellet. 2002. Induction
of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in
wild-type and daunorubicin-resistant HL-60 cell lines. Cancer Letters 188: 73-83.
